• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

20.60 -0.47 (-2.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT Investors With Large Losses in PROCEPT BioRobotics Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
July 27, 2026
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – PRCT
July 27, 2026
From The DJS Law Group
Via Business Wire
News headline image
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm
July 26, 2026
From The Schall Law Firm
Via Business Wire
PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) Q1 Earnings Beat Drives 13% Surge Despite Net Loss ↗
April 29, 2026
Via Chartmill
Topics Earnings
News headline image
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses
July 24, 2026
From Robbins LLP
Via Business Wire
News headline image
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors
July 15, 2026
From Mobia Medical, Inc.
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
July 14, 2026
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
May 28, 2026
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗
May 23, 2026
Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations. 
Via The Motley Fool
News headline image
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗
May 23, 2026
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
5 Robotics Stocks to Watch as Physical AI Builds Momentum ↗
May 18, 2026
Via MarketBeat
Topics Artificial Intelligence
News headline image
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
May 14, 2026
Update reflects growing clinical evidence and expanded adoption in practice 
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
April 30, 2026
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Procept (PRCT) Q1 2026 Earnings Transcript ↗
April 30, 2026
Procept (PRCT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
What's going on in today's after hours session ↗
April 29, 2026
Via Chartmill
News headline image
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
April 29, 2026
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock ↗
April 24, 2026
This surgical robotics firm develops minimally invasive systems for urologic procedures, targeting hospitals and specialty clinics. 
Via The Motley Fool
News headline image
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
April 22, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
April 22, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
April 22, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
PROCEPT BioRobotics (PRCT) Earnings Transcript ↗
April 14, 2026
PROCEPT BioRobotics (PRCT) Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
April 09, 2026
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
March 24, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
March 23, 2026
Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasia 
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
March 17, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
March 12, 2026
UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026 
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
March 10, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
March 10, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 10, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
March 09, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap